Natco Pharma Limited has announced the completion of a regulatory inspection from the United States Food and Drug Administration (USFDA) for its Formulation facility in Ramky SEZ, near Visakhapatnam (Vizag), India, which was conducted during the period 30th January, 2023 to 3rd February, 2023.

At the end of the inspection, the facility received two observations, one on written production process control procedure and the other on investigation procedure. The company is confident of addressing all observations within the stipulated time.